The Mother in Norway Study
Launched by OSLO METROPOLITAN UNIVERSITY · May 31, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
**Summary of The Mother in Norway Study**
The Mother in Norway Study is looking at a special program called the Nurse Family Partnership (NFP) to see how it can help new mothers and their children. This program aims to reduce issues like child abuse and social inequality by providing support to mothers during pregnancy and after giving birth. In this study, 700 expectant mothers will be enrolled over two years. Half of these mothers will receive the NFP services, which includes regular visits from a nurse, while the other half will get the usual care that is available. The study will mainly focus on how these services affect violence against mothers and their children and will also check how the program impacts overall health and wellness.
To participate in this study, mothers need to be female and currently pregnant, with less than 28 weeks left in their pregnancy. They should not have had a previous live birth and must live in an area served by the NFP. Importantly, mothers who are already part of the study or those who don’t need extra help during their pregnancy won’t be eligible. Those who take part can expect to answer questionnaires about their experiences and well-being, and they may also have visits from nurses who will provide support and information. This study is important as it aims to find effective ways to help mothers and improve their health and safety, while also looking at how cost-effective the NFP program is compared to standard care.
Gender
FEMALE
Eligibility criteria
- • Inclusion Criteria: Female; No previous live births; Currently pregnant; Gestation period less than 28 weeks (i.e., less than or equal to 27 weeks, 6 days) at time of recruitment; Live within an area serviced by a NFP Implementing Agency; Not currently enrolled in the study; professionals are concerned about the pregnancy / impending parenthood
- • Exclusion Criteria: Women who have had a previous live birth; Women who are not currently pregnant; Women who are past their 28th week of gestation (i.e., greater than or equal to 28 weeks, 0 days) at time of recruitment; Women who live outside of an area serviced by a NFP Implementing Agency; Women who are currently enrolled in the study; professionals are not concerned about the pregnancy / impending parenthood
About Oslo Metropolitan University
Oslo Metropolitan University (OsloMet) is a leading institution in Norway dedicated to advancing research and education in various fields, including health sciences, social sciences, and technology. With a strong commitment to fostering innovation and collaboration, OsloMet plays a pivotal role in conducting clinical trials that aim to improve healthcare outcomes and address pressing societal challenges. The university's interdisciplinary approach leverages expertise from diverse domains, ensuring robust methodologies and comprehensive analyses in its research initiatives. OsloMet is dedicated to contributing to evidence-based practices and enhancing the quality of life through its clinical research efforts.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bergen, , Norway
Kristiansand, , Norway
Oslo, , Norway
Sandnes, , Norway
Trondheim, , Norway
Patients applied
Trial Officials
Anne Grete Tøge, phd
Principal Investigator
Oslo Metropolitan University
Eirin Pedersen, phd
Principal Investigator
Oslo Metropolitan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported